Kirsty Ross Stewart

Stock Analyst at Exane BNP Paribas

(1.21)

# 3,465

Out of 4,339 analysts

Total ratings

50%

Success rate

-10.8%

Average return

Main Sectors:

Top Industries:

Stocks Rated by Kirsty Ross Stewart

	Stock	Action	Price Target	Current	Upside	Ratings	Updated
	ZLDPF Zealand Pharma A/S	Downgraded: Hold	$905 → $275	$50.26	+447.15%	2	Mar 6, 2026
	STO: SOBI Swedish Orphan Biovitrum AB (publ)	Upgraded: Buy	$475	$447.20	+6.22%	1	Feb 10, 2026

Zealand Pharma A/S

Mar 6, 2026

Downgraded: Hold

Price Target: $905 → $275

Current: $50.26

Upside: +447.15%

Swedish Orphan Biovitrum AB (publ)

Feb 10, 2026

Upgraded: Buy

Price Target: $475

Current: $447.20

Upside: +6.22%